Adena Healthcare Collaborative, LLC

ACO Name and Location

Adena Healthcare Collaborative, LLC
272 Hospital Road
Chillicothe, OH 45601

ACO Primary Contact

Joseph Zakrzewski
740-773-7398
jzakrzewski@adena.org

Organizational Information

ACO participants:

ACO Participants	ACO Participant in Joint Venture
Adena Medical Group, LLC	N

ACO governing body:

Member	Title/position	Member’s Voting Power	Membership Type	ACO Participant Legal Business Name/DBA if applicable
Jim McManus	Chairperson	20%	ACO Participant Representative	Adena Health System
Devin Zakrzewski		20%	ACO Participant Representative	Adena Health System
Katherine Edrington		20%	ACO Participant Representative	Adena Health System
Justin Smith, MD		20%	ACO Participant Representative	Adena Health System
William Beatty		20%	Medicare Beneficiary	Adena Health System

Key ACO clinical and administrative leadership:

Joseph Zakrzewski - ACO Executive
Justin Smith, MD - Medical Director
Kristin Boggs - Compliance Officer
Jessica Parsons - Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee Name	Committee Leader Name and Position
Finance and Clinical Quality Committee	Dr. Justin Smith, Chair
Value-Based Steering Committee	Jim McManus, CFO

Types of ACO participants, or combinations of participants, that formed the ACO:

Critical Access Hospital (CAH) billing under Method II
Hospital employing ACO professionals
Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

Second Agreement Period

Performance Year 2021, $0
Performance Year 2020, $0
Performance Year 2019, $0
Performance Year 2018, $0

First Agreement Period

Performance Year 2017, $0
Performance Year 2016, $4,453,320
Performance Year 2015, $2,551,721

Shared Savings Distribution

Third Agreement Period

Performance Year 2022
- Proportion invested in infrastructure: NA
- Proportion invested in redesigned care processes/resources: NA
- Proportion of distribution to ACO participants: NA

Second Agreement Period

Performance Year 2021
- Proportion invested in infrastructure: NA
- Proportion invested in redesigned care processes/resources: NA
- Proportion of distribution to ACO participants: NA
Performance Year 2020
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
Performance Year 2019
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
Performance Year 2018
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A

First Agreement Period

Performance Year 2017
- Proportion invested in infrastructure: NA
- Proportion invested in redesigned care processes/resources: NA
- Proportion of distribution to ACO participants: NA
Performance Year 2016
- Proportion invested in infrastructure: 28%
- Proportion invested in redesigned care processes/resources: 8%
- Proportion of distribution to ACO participants: 64%
Performance Year 2015
- Proportion invested in infrastructure: 25%
- Proportion invested in redesigned care processes/resources: n/a
- Proportion of distribution to ACO participants: 75%

Quality Performance Results

2022 Quality Performance Results:

Quality performance results are based on the CMS Web Interface collection type.

Measure #	Measure Name	Collection Type	Reported Performance Rate	Current Year Mean Performance Rate (SSP ACOs)
Quality ID# 001	Diabetes: Hemoglobin A1c (HbA1c) Poor Control [1]	CMS Web Interface	12.08	10.71
Quality ID# 134	Preventative Care and Screening: Screening for Depression and Follow-up Plan	CMS Web Interface	42.36	76.97
Quality ID# 236	Controlling High Blood Pressure	CMS Web Interface	71.31	76.16
Quality ID# 318	Falls: Screening for Future Fall Risk	CMS Web Interface	97.73	87.83
Quality ID# 110	Preventative Care and Screening: Influenza Immunization	CMS Web Interface	71.23	77.34
Quality ID# 226	Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention	CMS Web Interface	96.83	79.27
Quality ID# 113	Colorectal Cancer Screening	CMS Web Interface	74.19	75.32
Quality ID# 112	Breast Cancer Screening	CMS Web Interface	71.01	78.07
Quality ID# 438	Statin Therapy for the Prevention and Treatment of Cardiovascular Disease	CMS Web Interface	80.38	86.37
Quality ID# 370	Depression Remission at Twelve Months	CMS Web Interface	1.69	16.03
Quality ID# 321	CAHPS for MIPS [3]	CMS Web Interface	N/A	N/A
Measure# 479	Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups [1]	CMS Web Interface	0.1518	0.1510
Measure# 484	Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions [1]	CMS Web Interface	31.16	30.97
CAHPS-1	Getting Timely Care, Appointments, and Information	CAHPS for MIPS Survey	86.03	83.96
CAHPS-2	How Well Providers Communicate	CAHPS for MIPS Survey	94.12	93.47
CAHPS-3	Patient’s Rating of Provider	CAHPS for MIPS Survey	92.31	92.06
CAHPS-4	Access to Specialists	CAHPS for MIPS Survey	79.14	77.00
CAHPS-5	Health Promotion and Education	CAHPS for MIPS Survey	54.56	62.68
CAHPS-6	Shared Decision Making	CAHPS for MIPS Survey	58.22	60.97
CAHPS-7	Health Status and Functional Status	CAHPS for MIPS Survey	71.61	73.06
CAHPS-8	Care Coordination	CAHPS for MIPS Survey	87.92	85.46
CAHPS-9	Courteous and Helpful Office Staff	CAHPS for MIPS Survey	93.61	91.97
CAHPS-11	Stewardship of Patient Resources	CAHPS for MIPS Survey	25.46	25.62

For previous years’ Financial and Quality Performance Results, please visit: Data.cms.gov

Payment Rule Waivers

Skilled Nursing Facility (SNF) 3-Day Rule Waiver:
- Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612.
Waiver for Payment for Telehealth Services:

Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.61